JPRN-UMIN000008861已完成未知
Phase II study of weekly nanoparticle albumin-bound paclitaxel for patients with metastatic breast cancer (KSCOG-BC04) - Phase II study of weekly nanoparticle albumin-bound paclitaxel (KSCOG-BC04)
Department of Surgery, Kurume University School of Medicine0 个研究点目标入组 55 人开始时间: 2012年9月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Anamnesis of hypersensitivity to drugs(especially paclitaxel or albumin) 2) Ttreatment history of taxanes (paclitaxel or docetaxel) for metastatic breast cancer 3)Peripheral neuropathy Grade2 or over 4) Pregnancy, or suspected pregnancy 5)Severe Infection (38 degrees or over) 6)Severe complication (interstitial pneumonia or pulmonary fibrosis, renal failure, hepatic failure, uncontrolled diabetes, uncontrolled hypertension and so on) 7) ECG abnormalities 8)Heart failure with clinically problem (cardiac failure, cardiac infarction, angina, cardiac valvulopathy) 9) Active secondary malignancy within 5 years of disease free interval(but, registerable for cured cutaneous basal cell carcinomas and cervical cancer, cured gastric cancer, esophageal cancer and pm-colorectal cancer by endoscopic mucosal resection) 10)Pleural effusion, ascites, and pericardial effusion that need treat 11) Symptomatic brain metastasis 12)Consecutive systemic administration of steroids 13)Physician judged improper to entry this trial
研究者
相似试验
招募中
不适用
Feasibility study of weekly nanoparticle albumin-bound paclitaxel for patients with metastatic breast cancer (HBCC1101)Breast CancerJPRN-UMIN000007029Hokkaido Cancer Center40
招募中
2 期
Phase I Study of Nanoparticle albumin-bound paclitaxel and Cyclophosphamide combination chemotherapy for Patients with Metastatic Breast Cancer(GBCCSG-02)Primary breast cancerJPRN-UMIN000009973Gunma Breast Clinical Conference Study Group(GBCCSG)12
尚未招募
2 期
The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.Histological or Cytological Confirmed Stage Ⅲ and Ⅳa ThymomaNCT05816694Peng Liu50
已完成
2 期
Phase II study of weekly nanoparticle albumin-bound paclitaxel for patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy. (KTOSG1301)on-small cell lung cancerJPRN-UMIN000010532Department of Respiratory Medicine , Kumamoto University School of Medicine41
已完成
2 期
Phase II trial of a low dose nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.unrecectable or recurrent advanced gastric cancerJPRN-UMIN000015431Yokohama City University Medical Center34